Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target
Authors
Keywords
-
Journal
ONCOGENE
Volume 36, Issue 2, Pages 168-181
Publisher
Springer Nature
Online
2016-06-13
DOI
10.1038/onc.2016.197
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Erythropoietin Stimulates Tumor Growth via EphB4
- (2015) Sunila Pradeep et al. CANCER CELL
- Measuring Ovarian Cancer Care: Why Are We Still Failing?
- (2015) Barbara Goff GYNECOLOGIC ONCOLOGY
- Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth
- (2015) G. Gritsina et al. MOLECULAR CANCER THERAPEUTICS
- Role of malignant ascites on human mesothelial cells and their gene expression profiles
- (2014) Isabelle Matte et al. BMC CANCER
- Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread
- (2014) Sunila Pradeep et al. CANCER CELL
- A Specific STAT3-Binding Peptide Exerts Antiproliferative Effects and Antitumor Activity by Inhibiting STAT3 Phosphorylation and Signaling
- (2014) Daejin Kim et al. CANCER RESEARCH
- HO-3867, a Safe STAT3 Inhibitor, Is Selectively Cytotoxic to Ovarian Cancer
- (2014) Kellie S. Rath et al. CANCER RESEARCH
- Doxorubicin Synergizes with 34.5ENVE to Enhance Antitumor Efficacy against Metastatic Ovarian Cancer
- (2014) C. Bolyard et al. CLINICAL CANCER RESEARCH
- Bortezomib-Induced Unfolded Protein Response Increases Oncolytic HSV-1 Replication Resulting in Synergistic Antitumor Effects
- (2014) J. Y. Yoo et al. CLINICAL CANCER RESEARCH
- Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor
- (2014) Brent J. Tierney et al. GYNECOLOGIC ONCOLOGY
- Targeting JAK1/STAT3 Signaling Suppresses Tumor Progression and Metastasis in a Peritoneal Model of Human Ovarian Cancer
- (2014) W. Wen et al. MOLECULAR CANCER THERAPEUTICS
- JAK-STAT Blockade Inhibits Tumor Initiation and Clonogenic Recovery of Prostate Cancer Stem-like Cells
- (2013) P. Kroon et al. CANCER RESEARCH
- Pancreatic Cancer-Associated Stellate Cells Promote Differentiation of Myeloid-Derived Suppressor Cells in a STAT3-Dependent Manner
- (2013) T. A. Mace et al. CANCER RESEARCH
- Latest research and treatment of advanced-stage epithelial ovarian cancer
- (2013) Robert L. Coleman et al. Nature Reviews Clinical Oncology
- Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research
- (2013) Nuzhat Ahmed et al. Frontiers in Oncology
- HO-3867, a STAT3 inhibitor induces apoptosis by inactivation of STAT3 activity in BRCA1-mutated ovarian cancer cells
- (2012) Brent J. Tierney et al. CANCER BIOLOGY & THERAPY
- Leukotriene B4Receptor-2 Promotes Invasiveness and Metastasis of Ovarian Cancer Cells through Signal Transducer and Activator of Transcription 3 (STAT3)-dependent Up-regulation of Matrix Metalloproteinase 2
- (2012) Ji-Min Seo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors
- (2012) Ardian Latifi et al. PLoS One
- Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts
- (2012) X. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells
- (2011) Han-Shui Hsu et al. CANCER
- Cellular uptake, retention and bioabsorption of HO-3867, a fluorinated curcumin analog with potential antitumor properties
- (2011) Alex Dayton et al. CANCER BIOLOGY & THERAPY
- Synthesis of N-Substituted 3,5-Bis(arylidene)-4-piperidones with High Antitumor and Antioxidant Activity
- (2011) Tamás Kálai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- Synthesis and cytotoxicity of novel indirubin-5-carboxamides
- (2010) Xinlai Cheng et al. BIOORGANIC & MEDICINAL CHEMISTRY
- More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer
- (2010) Tracy Putoczki et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity
- (2010) Matthew A Bill et al. Molecular Cancer
- HO-3867, a Synthetic Compound, Inhibits the Migration and Invasion of Ovarian Carcinoma Cells through Downregulation of Fatty Acid Synthase and Focal Adhesion Kinase
- (2010) K. Selvendiran et al. MOLECULAR CANCER RESEARCH
- Anticancer Efficacy of a Difluorodiarylidenyl Piperidone (HO-3867) in Human Ovarian Cancer Cells and Tumor Xenografts
- (2010) K. Selvendiran et al. MOLECULAR CANCER THERAPEUTICS
- Peering into the aftermath: JAKi rips STAT3 in cancer
- (2010) Florian R Greten et al. NATURE MEDICINE
- STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors
- (2010) Heehyoung Lee et al. NATURE MEDICINE
- Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors
- (2010) V. Vaira et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3
- (2009) Karuppaiyah Selvendiran et al. INTERNATIONAL JOURNAL OF CANCER
- Knockdown of STAT3 by shRNA inhibits the growth of CAOV3 ovarian cancer cell linein vitroandin vivo
- (2008) Feng Huang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started